Josep Carreras Leukaemia Research Institute
In research, Josep Carreras Leukaemia Research Institute stands highest in Life Sciences (#2,310 of 7,800 worldwide), Medicine (#4,602 of 10,443 worldwide) and Health Sciences (#6,221 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Molecular Biology — Molecular Biology is 8.0× its share of world research.
- World rank, 2022–2025
- #5,674 of 28,054 · #12,236 all time
- Rank in Spain
- #153 of 658
- Research works
- 367 ▲ 183% vs 2013–17
- Citations
- 7.4k 20.1 per fractional work
- Top-10% rate
- 22.1% record average 16.5%
- Open access
- 63% world 28%
What is Josep Carreras Leukaemia Research Institute known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #2,310 of 7,800 | 27.1% | 72 | #4865 | |
| MedicineField | #4,602 of 10,443 | 18.5% | 87 | #9452 | |
| Health SciencesDomain | #6,221 of 11,982 | 18.5% | 89 | #12436 |
Each strip is that field’s whole ranked pool, with the notch where Josep Carreras Leukaemia Research Institute sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#4,865 #2,310
- Medicine#9,452 #4,602
- Health Sciences#12,436 #6,221
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Josep Carreras Leukaemia Research Institute specialise in?
Where its research is concentrated relative to its size: Molecular Biology takes 8.0× the share of its output that it takes of world research.
- Molecular BiologySubfield · 40.8 works8.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.7×. Every wedge is a field page.
- Immunology and Microbiology 7.7×
- Biochemistry, Genetics and Molecular Biology 6.2×
- Medicine 2.7×
- Pharmacology, Toxicology and Pharmaceutics 1.1×
- Neuroscience 0.5×
- Nursing 0.3×
- Dentistry 0.3×
- Agricultural and Biological Sciences 0.2×
- Chemistry 0.2×
- Materials Science 0.2×
- Health Professions 0.2×
- Economics, Econometrics and Finance 0.1×
- Decision Sciences 0.1×
- Environmental Science 0.1×
- Mathematics 0.1×
- Computer Science 0.1×
- Physics and Astronomy 0.1×
- Engineering 0.1×
- Psychology 0.0×
- Social Sciences 0.0×
- Business, Management and Accounting 0.0×
- Veterinary 0.0×
- Arts and Humanities 0.0×
Who are the top researchers at Josep Carreras Leukaemia Research Institute?
Ranked on the composite score, Isabel Granada, Laura Palomo and Pablo Menéndez lead among researchers whose main affiliation is Josep Carreras Leukaemia Research Institute.
- 1 Isabel Granada Spain · #194,349 worldwide 120 citations · 25 works
- 2 Laura Palomo Spain · #507,849 worldwide 21 citations · 19 works
- 3 Pablo Menéndez Spain · #1,213,665 worldwide 37 citations · 56 works
- 4 Esteban Ballestar Spain · #1,215,001 worldwide 54 citations · 43 works
- 5 Clara Bueno Spain · #1,506,891 worldwide 27 citations · 22 works
Which keywords describe research at Josep Carreras Leukaemia Research Institute?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Hematopoietic Stem Cells, Cancer, Lymphoma, Minimal Residual Disease, Rituximab, DNA Methylation and Immunotherapy.
- Piezo1
- Transcriptional Regulation
- Mutation
- Chronic Lymphocytic Leukemia
- PET Imaging
- Immunity
- Therapeutic Targets
- CAR T Cells
- Leukemia
- Pediatric Oncology
- Childhood Cancer
- Epigenetic Regulation
- Gene Expression
- AML
- Cancer Epigenetics
- Epigenetic Reprogramming
- DNA Methylation
- Minimal Residual Disease
- Lymphoma
- Cancer
- Prognostic Factors
- Hematopoietic Stem Cells
- Inflammation
- Immunotherapy
- Rituximab
- Cancer Immunotherapy
- Histone Modification
- Acute Myeloid Leukemia
- Cancer Therapy
- Acute Lymphoblastic Leukemia
- Genetic Alterations
- Tumor Regression
- Apoptosis
- Chimeric Antigen Receptor
- Cancer Progression
- Mechanotransduction
- Tumor Microenvironment
- Genomic Aberrations
- Erythropoiesis
- Gene Expression Regulation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Prognostic Factors19▲ 26×10 topics
- Cancer11▲ 5.0×35 topics
- Hematopoietic Stem Cells11▲ 75×3 topics
- Lymphoma9▲ 33×3 topics
- Inflammation9▲ 2.5×46 topics
- Minimal Residual Disease9▲ 74×2 topics
- Immunotherapy8▲ 7.1×16 topics
- DNA Methylation8▲ 43×2 topics
- Rituximab8▲ 33×3 topics
- Epigenetic Reprogramming8▲ 52×2 topics
- Cancer Immunotherapy8▲ 31×3 topics
- Cancer Epigenetics8▲ 66×1 topic
- Histone Modification8▲ 66×1 topic
- AML7▲ 90×1 topic
- Acute Myeloid Leukemia7▲ 90×1 topic
- Gene Expression7▲ 7.2×12 topics
- Cancer Therapy7▲ 7.4×12 topics
- Epigenetic Regulation6▲ 18×5 topics
- Acute Lymphoblastic Leukemia6▲ 110×1 topic
- Childhood Cancer6▲ 110×1 topic
- Genetic Alterations6▲ 48×2 topics
- Pediatric Oncology6▲ 67×2 topics
- Tumor Regression6▲ 33×2 topics
- Leukemia6▲ 39×2 topics
- Apoptosis5▲ 11×13 topics
- CAR T Cells5▲ 43×1 topic
- Chimeric Antigen Receptor5▲ 43×1 topic
- Therapeutic Targets5▲ 21×4 topics
- Cancer Progression5▲ 16×8 topics
- Immunity5▲ 7.2×8 topics
- Mechanotransduction5▲ 45×4 topics
- PET Imaging5▲ 16×4 topics
- Tumor Microenvironment5▲ 6.3×8 topics
- Chronic Lymphocytic Leukemia5▲ 61×1 topic
- Genomic Aberrations5▲ 61×1 topic
- Mutation5▲ 14×5 topics
- Erythropoiesis4▲ 44×2 topics
- Transcriptional Regulation4▲ 17×7 topics
- Gene Expression Regulation4▲ 24×3 topics
- Piezo14▲ 113×1 topic
Which research topics does Josep Carreras Leukaemia Research Institute publish most on?
By volume in 2022–2025: Epigenetics and DNA Methylation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Epigenetics and DNA Methylation Molecular Biology 8 works
- 2 Acute Myeloid Leukemia Research Hematology 7 works
- 3 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 6 works
- 4 CAR-T cell therapy research Oncology 5 works
- 5 Chronic Lymphocytic Leukemia Research Genetics 5 works
- 6 Erythrocyte Function and Pathophysiology Physiology 4 works
- 7 RNA modifications and cancer Molecular Biology 4 works
- 8 Chronic Myeloid Leukemia Treatments Hematology 4 works
- 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
- 10 Hematopoietic Stem Cell Transplantation Hematology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Josep Carreras Leukaemia Research Institute's research output changed?
Output in 2018–2022 was 183% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Barcelona
- Universitat de Barcelona
- Universitat Politècnica de Catalunya
- Universitat Pompeu Fabra
- Hospital Clínic de Barcelona
- Vall d'Hebron Hospital Universitari
- Hospital de Sant Pau
- Universitat Oberta de Catalunya
- Institució Catalana de Recerca i Estudis Avançats
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.